Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2015-10-29 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VAL D'OUST (56460), Morbihan
PHARMACIE ANAEL FROMENTIN : revenue, balance sheet and financial ratios
PHARMACIE ANAEL FROMENTIN is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VAL D'OUST (56460),
this company of category PME
shows in 2022 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ANAEL FROMENTIN (SIREN 814494126)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 560 291 €
N/C
1 339 975 €
1 412 027 €
1 331 933 €
1 285 120 €
1 455 757 €
Net income
43 724 €
50 837 €
97 239 €
83 796 €
88 901 €
78 157 €
87 405 €
85 704 €
6 467 €
EBITDA
N/C
N/C
99 624 €
N/C
102 209 €
73 279 €
87 106 €
87 350 €
205 €
Net margin
N/C
N/C
6.2%
N/C
6.6%
5.5%
6.6%
6.7%
0.4%
Revenue and income statement
In 2024, PHARMACIE ANAEL FROMENTIN generates positive net income of 44 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 6 k€ -> 44 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
43 724 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
48.706%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
58.03%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
984.118
500.439
311.771
224.534
158.809
116.967
82.466
62.472
48.706
Financial autonomy
8.275
14.745
22.307
27.66
34.511
41.907
47.134
52.898
58.03
Repayment capacity
78.945
10.893
10.261
11.268
7.993
None
1.97
None
None
Cash flow / Revenue
0.912%
6.87%
6.377%
5.048%
6.598%
None%
6.269%
None%
None%
Sector positioning
Debt ratio
48.712024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-8 pts over 3 years
In 2024, the debt ratio of PHARMACIE ANAEL FROMENTIN (48.71) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
58.03%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+10 pts over 3 years
In 2024, the financial autonomy of PHARMACIE ANAEL FROMENTIN (58.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
1.97 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE ANAEL FROMENTIN (1.97) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 96.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
141.711
146.105
170.07
150.547
146.31
145.956
48.015
39.812
96.008
Interest coverage
8418.537
16.39
14.971
16.091
10.345
None
7.849
None
None
Sector positioning
Liquidity ratio
96.012024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch+10 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE ANAEL FROMENTIN (96.01) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
7.85x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE ANAEL FROMENTIN (7.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE ANAEL FROMENTIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
128 092 €
85 011 €
153 479 €
149 392 €
132 108 €
0 €
139 084 €
0 €
0 €
Inventory turnover (days)
30
30
32
31
33
0
27
0
0
Customer payment term (days)
5
6
6
6
8
0
7
0
0
Supplier payment term (days)
23
33
29
33
38
0
46
0
0
Positioning of PHARMACIE ANAEL FROMENTIN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE ANAEL FROMENTIN is estimated at
610 419 €
(range 425 086€ - 913 222€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
425k€610k€913k€
610 419 €Range: 425 086€ - 913 222€
NAF 5 année 2024
Valuation method used
Net Income Multiple
43 724 €
×
14.0x
=610 419 €
Range: 425 086€ - 913 222€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ANAEL FROMENTIN with other companies in the same sector:
Frequently asked questions about PHARMACIE ANAEL FROMENTIN
What is the revenue of PHARMACIE ANAEL FROMENTIN ?
The revenue of PHARMACIE ANAEL FROMENTIN in 2022 is 1.6 M€.
Is PHARMACIE ANAEL FROMENTIN profitable?
Yes, PHARMACIE ANAEL FROMENTIN generated a net profit of 44 k€ in 2024.
Where is the headquarters of PHARMACIE ANAEL FROMENTIN ?
The headquarters of PHARMACIE ANAEL FROMENTIN is located in VAL D'OUST (56460), in the department Morbihan.
Where to find the tax return of PHARMACIE ANAEL FROMENTIN ?
The tax return of PHARMACIE ANAEL FROMENTIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ANAEL FROMENTIN operate?
PHARMACIE ANAEL FROMENTIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart